Paul Weiss
QuietNamed in filings at Venture Investors HealthOn the current fund
- Board seats filed
- 9
Named in filings at Venture Investors HealthOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Ten Bay Bio | Not yet classified | July 2024 | None on file |
| Invenra | Biotech & pharma | October 2018 | None on file |
| Aerpio Pharmaceuticals | Biotech & pharma | March 2017 | None on file |
| FLUGEN | Biotech & pharma | August 2015 | None on file |
| Tamir Biotechnology | Biotech & pharma | April 2014 | None on file |
| Neurovance | Biotech & pharma | March 2012 | None on file |
| EBI Life Sciences | Biotech & pharma | March 2012 | None on file |
| Aerpio Therapeutics | Biotech & pharma | December 2011 | None on file |
| Euthymics Bioscience | Biotech & pharma | July 2010 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Paul Weiss on the board, based on 8 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.